US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist

27.570
-0.310-1.11%

Trading Nov 29 12:34 ET

485.65MMarket Cap102.11P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

1,695.22%21.68M

-94.91%302K

-23.05%-5.01M

92.21%-5.74M

71.52%-6.24M

89.78%-1.36M

145.93%5.93M

84.11%-4.07M

-1,354.81%-73.76M

-14.79%-21.91M

Net income from continuing operations

318.22%12.42M

84.39%-1.03M

39.07%-8.25M

57.16%-25.09M

-47.39%737K

70.10%-5.69M

51.08%-6.6M

50.68%-13.54M

-226.97%-58.57M

106.19%1.4M

Operating gains losses

----

292.75%266K

-133.64%-110K

89.62%-22K

--51K

--347K

---138K

--327K

Depreciation and amortization

109.25%611K

107.09%613K

12.04%400K

24.05%1.24M

3.17%293K

21.67%292K

24.89%296K

50.63%357K

-14.11%998K

-29.70%284K

Other non cash items

----

-78.27%682K

--0

Change In working capital

173.93%6.1M

-116.41%-1.65M

-134.53%-2.1M

132.76%9.52M

68.25%-8.83M

-25.64%2.23M

636.95%10.06M

358.65%6.07M

-398.92%-29.05M

-21,467.44%-27.82M

-Change in receivables

38.72%-1.67M

-116.29%-1.39M

-72.27%3.04M

139.32%9.77M

71.75%-7M

-263.00%-2.73M

536.52%8.55M

4,621.55%10.95M

-5,059.68%-24.85M

-5,054.89%-24.8M

-Change in inventory

1,090.04%3.34M

-810.36%-2.2M

-18.52%-2.31M

149.31%1.17M

227.63%2.53M

132.04%281K

-48.07%309K

-1,640.18%-1.95M

51.24%-2.38M

-540.67%-1.98M

-Change in prepaid assets

-172.03%-1.4M

-83.46%496K

-759.18%-2.58M

335.89%2M

-58.47%-3.33M

8.75%1.94M

103.18%3M

119.57%392K

-112.77%-847K

-42.03%-2.1M

-Change in payables and accrued expense

-76.33%640K

3.64%-2.17M

184.54%2.85M

-302.48%-5.71M

-155.96%-2.79M

308.96%2.7M

27.59%-2.25M

-250.99%-3.37M

-48.82%2.82M

608.97%4.99M

-Change in other current assets

1,509.09%155K

442.86%152K

-83.54%149K

-86.12%1.13M

-77.57%203K

-100.51%-11K

-98.81%28K

-66.24%905K

0.81%8.11M

-56.53%905K

-Change in other current liabilities

92.04%-173K

27.35%-170K

-142.21%-168K

83.41%-2.17M

97.25%-162K

12.98%-2.17M

90.01%-234K

116.90%398K

-51.77%-13.08M

-163.25%-5.89M

-Change in other working capital

134.79%5.2M

449.85%3.63M

-143.19%-3.07M

182.87%3.34M

64.35%1.72M

8.91%2.21M

-41.02%660K

58.23%-1.26M

-53.33%1.18M

-58.34%1.05M

Cash from discontinued investing activities

Operating cash flow

1,695.22%21.68M

-94.91%302K

-23.05%-5.01M

92.21%-5.74M

71.52%-6.24M

89.78%-1.36M

145.93%5.93M

84.11%-4.07M

-1,354.81%-73.76M

-14.79%-21.91M

Investing cash flow

Cash flow from continuing investing activities

424.96%3.8M

267.98%10.93M

-59.72%313K

-105.90%-4.3M

-136.96%-6.87M

-111.19%-1.17M

-85.92%2.97M

-96.57%777K

190.93%72.78M

186.65%18.6M

Net PPE purchase and sale

18.18%26K

--0

-41.53%259K

-60.29%110K

-75.56%22K

--0

156.70%127K

170.65%443K

--277K

Net intangibles purchase and sale

--0

---222K

99.08%-138K

---15M

--0

---15M

--0

Net investment purchase and sale

417.62%3.79M

275.45%11.15M

-97.12%451K

-85.56%10.44M

-138.12%-6.98M

-111.50%-1.19M

-85.72%2.97M

-31.52%15.65M

191.09%72.33M

183.30%18.32M

Cash from discontinued investing activities

Investing cash flow

424.96%3.8M

267.98%10.93M

-59.72%313K

-105.90%-4.3M

-136.96%-6.87M

-111.19%-1.17M

-85.92%2.97M

-96.57%777K

190.93%72.78M

186.65%18.6M

Financing cash flow

Cash flow from continuing financing activities

-1,032.57%-9.84M

-101.61%-752K

-113.14%-2.51M

180.41%18.37M

123.19%486K

-115.77%-869K

93.41%-373K

117.38%19.12M

-89.55%6.55M

-293.18%-2.1M

Net issuance payments of debt

--0

2.09%19.95M

--0

100.00%19.95M

--19.54M

--0

Proceeds from stock option exercised by employees

1,655.56%158K

-54.43%252K

8,800.00%89K

-50.61%1.05M

-16.92%486K

--9K

-7.68%553K

-99.89%1K

-55.52%2.12M

-46.08%585K

Net other financing activities

-1,038.95%-10M

-8.42%-1M

-214.13%-2.6M

82.59%-2.63M

--0

78.53%-878K

85.13%-926K

60.91%-828K

-126.11%-15.12M

---2.68M

Cash from discontinued financing activities

Financing cash flow

-1,032.57%-9.84M

-101.61%-752K

-113.14%-2.51M

180.41%18.37M

123.19%486K

-115.77%-869K

93.41%-373K

117.38%19.12M

-89.55%6.55M

-293.18%-2.1M

Net cash flow

Beginning cash position

-26.14%36.05M

-36.52%25.57M

34.04%32.79M

29.48%24.46M

52.06%45.41M

79.45%48.81M

63.24%40.29M

29.48%24.46M

-37.81%18.89M

-1.77%29.87M

Current changes in cash

560.24%15.64M

22.89%10.48M

-145.57%-7.21M

49.52%8.33M

-133.55%-12.63M

-227.50%-3.4M

238.10%8.53M

173.38%15.83M

148.50%5.57M

53.04%-5.41M

End cash Position

13.82%51.69M

-26.14%36.05M

-36.52%25.57M

34.04%32.79M

52.06%45.41M

79.45%48.81M

63.24%40.29M

29.48%24.46M

Free cash flow

1,694.48%21.67M

-98.65%80K

72.99%-5.15M

72.05%-20.74M

71.61%-6.24M

89.93%-1.36M

146.06%5.93M

26.24%-19.07M

-1,513.22%-74.21M

-15.30%-21.98M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	1,695.22%21.68M	-94.91%302K	-23.05%-5.01M	92.21%-5.74M	71.52%-6.24M	89.78%-1.36M	145.93%5.93M	84.11%-4.07M	-1,354.81%-73.76M	-14.79%-21.91M
Net income from continuing operations	318.22%12.42M	84.39%-1.03M	39.07%-8.25M	57.16%-25.09M	-47.39%737K	70.10%-5.69M	51.08%-6.6M	50.68%-13.54M	-226.97%-58.57M	106.19%1.4M
Operating gains losses	----	----	----	292.75%266K	-133.64%-110K	89.62%-22K	--51K	--347K	---138K	--327K
Depreciation and amortization	109.25%611K	107.09%613K	12.04%400K	24.05%1.24M	3.17%293K	21.67%292K	24.89%296K	50.63%357K	-14.11%998K	-29.70%284K
Other non cash items	----	----	----	----	----	----	----	----	-78.27%682K	--0
Change In working capital	173.93%6.1M	-116.41%-1.65M	-134.53%-2.1M	132.76%9.52M	68.25%-8.83M	-25.64%2.23M	636.95%10.06M	358.65%6.07M	-398.92%-29.05M	-21,467.44%-27.82M
-Change in receivables	38.72%-1.67M	-116.29%-1.39M	-72.27%3.04M	139.32%9.77M	71.75%-7M	-263.00%-2.73M	536.52%8.55M	4,621.55%10.95M	-5,059.68%-24.85M	-5,054.89%-24.8M
-Change in inventory	1,090.04%3.34M	-810.36%-2.2M	-18.52%-2.31M	149.31%1.17M	227.63%2.53M	132.04%281K	-48.07%309K	-1,640.18%-1.95M	51.24%-2.38M	-540.67%-1.98M
-Change in prepaid assets	-172.03%-1.4M	-83.46%496K	-759.18%-2.58M	335.89%2M	-58.47%-3.33M	8.75%1.94M	103.18%3M	119.57%392K	-112.77%-847K	-42.03%-2.1M
-Change in payables and accrued expense	-76.33%640K	3.64%-2.17M	184.54%2.85M	-302.48%-5.71M	-155.96%-2.79M	308.96%2.7M	27.59%-2.25M	-250.99%-3.37M	-48.82%2.82M	608.97%4.99M
-Change in other current assets	1,509.09%155K	442.86%152K	-83.54%149K	-86.12%1.13M	-77.57%203K	-100.51%-11K	-98.81%28K	-66.24%905K	0.81%8.11M	-56.53%905K
-Change in other current liabilities	92.04%-173K	27.35%-170K	-142.21%-168K	83.41%-2.17M	97.25%-162K	12.98%-2.17M	90.01%-234K	116.90%398K	-51.77%-13.08M	-163.25%-5.89M
-Change in other working capital	134.79%5.2M	449.85%3.63M	-143.19%-3.07M	182.87%3.34M	64.35%1.72M	8.91%2.21M	-41.02%660K	58.23%-1.26M	-53.33%1.18M	-58.34%1.05M
Cash from discontinued investing activities
Operating cash flow	1,695.22%21.68M	-94.91%302K	-23.05%-5.01M	92.21%-5.74M	71.52%-6.24M	89.78%-1.36M	145.93%5.93M	84.11%-4.07M	-1,354.81%-73.76M	-14.79%-21.91M
Investing cash flow
Cash flow from continuing investing activities	424.96%3.8M	267.98%10.93M	-59.72%313K	-105.90%-4.3M	-136.96%-6.87M	-111.19%-1.17M	-85.92%2.97M	-96.57%777K	190.93%72.78M	186.65%18.6M
Net PPE purchase and sale	18.18%26K	--0	--0	-41.53%259K	-60.29%110K	-75.56%22K	--0	156.70%127K	170.65%443K	--277K
Net intangibles purchase and sale	--0	---222K	99.08%-138K	---15M	--0	--0	--0	---15M	--0	--0
Net investment purchase and sale	417.62%3.79M	275.45%11.15M	-97.12%451K	-85.56%10.44M	-138.12%-6.98M	-111.50%-1.19M	-85.72%2.97M	-31.52%15.65M	191.09%72.33M	183.30%18.32M
Cash from discontinued investing activities
Investing cash flow	424.96%3.8M	267.98%10.93M	-59.72%313K	-105.90%-4.3M	-136.96%-6.87M	-111.19%-1.17M	-85.92%2.97M	-96.57%777K	190.93%72.78M	186.65%18.6M
Financing cash flow
Cash flow from continuing financing activities	-1,032.57%-9.84M	-101.61%-752K	-113.14%-2.51M	180.41%18.37M	123.19%486K	-115.77%-869K	93.41%-373K	117.38%19.12M	-89.55%6.55M	-293.18%-2.1M
Net issuance payments of debt	--0	--0	--0	2.09%19.95M	--0	--0	--0	100.00%19.95M	--19.54M	--0
Proceeds from stock option exercised by employees	1,655.56%158K	-54.43%252K	8,800.00%89K	-50.61%1.05M	-16.92%486K	--9K	-7.68%553K	-99.89%1K	-55.52%2.12M	-46.08%585K
Net other financing activities	-1,038.95%-10M	-8.42%-1M	-214.13%-2.6M	82.59%-2.63M	--0	78.53%-878K	85.13%-926K	60.91%-828K	-126.11%-15.12M	---2.68M
Cash from discontinued financing activities
Financing cash flow	-1,032.57%-9.84M	-101.61%-752K	-113.14%-2.51M	180.41%18.37M	123.19%486K	-115.77%-869K	93.41%-373K	117.38%19.12M	-89.55%6.55M	-293.18%-2.1M
Net cash flow
Beginning cash position	-26.14%36.05M	-36.52%25.57M	34.04%32.79M	29.48%24.46M	52.06%45.41M	79.45%48.81M	63.24%40.29M	29.48%24.46M	-37.81%18.89M	-1.77%29.87M
Current changes in cash	560.24%15.64M	22.89%10.48M	-145.57%-7.21M	49.52%8.33M	-133.55%-12.63M	-227.50%-3.4M	238.10%8.53M	173.38%15.83M	148.50%5.57M	53.04%-5.41M
End cash Position	13.82%51.69M	-26.14%36.05M	-36.52%25.57M	34.04%32.79M	34.04%32.79M	52.06%45.41M	79.45%48.81M	63.24%40.29M	29.48%24.46M	29.48%24.46M
Free cash flow	1,694.48%21.67M	-98.65%80K	72.99%-5.15M	72.05%-20.74M	71.61%-6.24M	89.93%-1.36M	146.06%5.93M	26.24%-19.07M	-1,513.22%-74.21M	-15.30%-21.98M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data